A researcher in the Unites states is examining the possibility of adopting the new vitro gametogenesis (IVG) treatment for human after its successful tests on mice.
The vitro gametogenesis (IVG) is the new frontier for research after the successful usage of IVF for human beings. Professor Sonia Suter from George Washington University is studying the possibility of suing the new technique for human reproduction as well as its ethical and practical implications. This method can seriously help same-sex couples have children biologically related to both partners.IVG is a technique by which, gametes are derived from pluripotent stem cellsor embryonic stem cells. The IVG in humans might allow absolutely new methods of procreation.
Professor Sonia Suter is studying potential benefits and harms of IVG and analysing social, scientific, and legal contexts relating to the treatment. Experts said that the treatment could benefit those who cannot conceive for physical reasons, same-sex couples, postmenopausal women or premenarche girls, and groups of more than two.
Professor Suter, “IVG could play a role in efforts to have a healthy or enhanced child by making prenatal selection much easier and more robust. It could, for example, be used to create many more embryos for preimplantation genetic diagnosis than we can today, vastly refining the ability to select embryos.”
The paper was published in the Journal of Law and the Biosciences.
In its annual Environmental Responsibility Report for fiscal year 2015 released last Thursday, tech giant Apple has revealed that nearly 90 million pounds of unwanted or broken electronics were processed by the company over the last one year....
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
There are a lot of things not going right at the IRS and...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).